{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:34:54Z","timestamp":1790926494123,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG066165"],"award-info":[{"award-number":["R01AG066165"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-06810-5","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:07:24Z","timestamp":1725523644000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lysosomal TMEM106B interacts with galactosylceramidase to regulate myelin lipid metabolism"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-4969-977X","authenticated-orcid":false,"given":"Hideyuki","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azucena","family":"Perez-Canamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9068-5274","authenticated-orcid":false,"given":"Chris W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-2413","authenticated-orcid":false,"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-3092","authenticated-orcid":false,"given":"Stephen M.","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"6810_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00401-020-02246-3","volume":"141","author":"T Feng","year":"2021","unstructured":"Feng, T., Lacrampe, A. & Hu, F. Physiological and pathological functions of TMEM106B: a gene associated with brain aging and multiple brain disorders. Acta Neuropathol. 141, 327\u2013339 (2021).","journal-title":"Acta Neuropathol."},{"key":"6810_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00401-022-02486-5","volume":"144","author":"J Perneel","year":"2022","unstructured":"Perneel, J. & Rademakers, R. Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease. Acta Neuropathol. 144, 807\u2013819 (2022).","journal-title":"Acta Neuropathol."},{"key":"6810_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/ng.536","volume":"42","author":"VM Van Deerlin","year":"2010","unstructured":"Van Deerlin, V. M. et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet 42, 234\u2013239 (2010).","journal-title":"Nat. Genet"},{"key":"6810_CR4","doi-asserted-by":"publisher","unstructured":"Bellenguez, C. et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. https:\/\/doi.org\/10.1038\/s41588-022-01024-z (2022).","DOI":"10.1038\/s41588-022-01024-z"},{"key":"6810_CR5","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat. Genet. 53, 1276\u20131282 (2021).","journal-title":"Nat. Genet."},{"key":"6810_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01883-5","volume":"19","author":"Y Hu","year":"2021","unstructured":"Hu, Y. et al. rs1990622 variant associates with Alzheimer\u2019s disease and regulates TMEM106B expression in human brain tissues. BMC Med. 19, 11 (2021).","journal-title":"BMC Med."},{"key":"6810_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s40478-018-0619-9","volume":"6","author":"JD Cherry","year":"2018","unstructured":"Cherry, J. D. et al. Variation in TMEM106B in chronic traumatic encephalopathy. Acta Neuropathol. Commun. 6, 115 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"6810_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson, P. T. et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142, 1503\u20131527 (2019).","journal-title":"Brain"},{"key":"6810_CR9","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1093\/brain\/awx314","volume":"140","author":"C Simons","year":"2017","unstructured":"Simons, C. et al. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy. Brain 140, 3105\u20133111 (2017).","journal-title":"Brain"},{"key":"6810_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05013-x","volume":"9","author":"ST Kundu","year":"2018","unstructured":"Kundu, S. T. et al. TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins. Nat. Commun. 9, 2731 (2018).","journal-title":"Nat. Commun."},{"key":"6810_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04572-3","volume":"9","author":"CL Grzeskowiak","year":"2018","unstructured":"Grzeskowiak, C. L. et al. In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat. Commun. 9, 2732 (2018).","journal-title":"Nat. Commun."},{"key":"6810_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41588-021-00805-2","volume":"53","author":"J Baggen","year":"2021","unstructured":"Baggen, J. et al. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat. Genet. 53, 435\u2013444 (2021).","journal-title":"Nat. Genet."},{"key":"6810_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cell.2020.12.006","volume":"184","author":"WM Schneider","year":"2021","unstructured":"Schneider, W. M. et al. Genome-scale identification of SARS-CoV-2 and Pan-coronavirus host factor networks. Cell 184, 120\u2013132.e114 (2021).","journal-title":"Cell"},{"key":"6810_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cell.2020.12.004","volume":"184","author":"R Wang","year":"2021","unstructured":"Wang, R. et al. Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell 184, 106\u2013119.e114 (2021).","journal-title":"Cell"},{"key":"6810_CR15","doi-asserted-by":"publisher","unstructured":"Chang, A. et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell. https:\/\/doi.org\/10.1016\/j.cell.2022.02.026 (2022).","DOI":"10.1016\/j.cell.2022.02.026"},{"key":"6810_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41422-022-00665-3","volume":"32","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. Generic amyloid fibrillation of TMEM106B in patient with Parkinson\u2019s disease dementia and normal elders. Cell Res. 32, 585\u2013588 (2022).","journal-title":"Cell Res."},{"key":"6810_CR17","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41586-022-04670-9","volume":"605","author":"YX Jiang","year":"2022","unstructured":"Jiang, Y. X. et al. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature 605, 304\u2013309 (2022).","journal-title":"Nature"},{"key":"6810_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04650-z","volume":"605","author":"M Schweighauser","year":"2022","unstructured":"Schweighauser, M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310\u2013314 (2022).","journal-title":"Nature"},{"key":"6810_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/d41586-022-00873-2","volume":"605","author":"H Takahashi","year":"2022","unstructured":"Takahashi, H. & Strittmatter, S. M. An unexpected protein aggregate in diseased and ageing brains. Nature 605, 227\u2013228 (2022).","journal-title":"Nature"},{"key":"6810_CR20","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1093\/brain\/awad133","volume":"146","author":"C T Vicente","year":"2023","unstructured":"T Vicente, C. et al. C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes. Brain 146, 4055\u20134064 (2023).","journal-title":"Brain"},{"key":"6810_CR21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-023-00650-3","volume":"18","author":"JY Lee","year":"2023","unstructured":"Lee, J. Y. et al. The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus. Mol. Neurodegener. 18, 63 (2023).","journal-title":"Mol. Neurodegener."},{"key":"6810_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf9735","volume":"16","author":"JD Marks","year":"2024","unstructured":"Marks, J. D. et al. TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia. Sci. Transl. Med 16, eadf9735 (2024).","journal-title":"Sci. Transl. Med"},{"key":"6810_CR23","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1016\/j.cell.2021.08.002","volume":"184","author":"T Logan","year":"2021","unstructured":"Logan, T. et al. Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. Cell 184, 4651\u20134668.e4625 (2021).","journal-title":"Cell"},{"key":"6810_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33500-9","volume":"13","author":"S Boland","year":"2022","unstructured":"Boland, S. et al. Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis. Nat. Commun. 13, 5924 (2022).","journal-title":"Nat. Commun."},{"key":"6810_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40478-023-01544-7","volume":"11","author":"OC Marian","year":"2023","unstructured":"Marian, O. C. et al. Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations. Acta Neuropathol. Commun. 11, 52 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"6810_CR26","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.celrep.2017.08.056","volume":"20","author":"BM Evers","year":"2017","unstructured":"Evers, B. M. et al. Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency. Cell Rep. 20, 2565\u20132574 (2017).","journal-title":"Cell Rep."},{"key":"6810_CR27","doi-asserted-by":"crossref","unstructured":"Han, X. Lipidomics: Comprehensive Mass Spectrometry of Lipids\/Xianlin Han. (John Wiley & Sons, Inc., Hoboken, New Jersey, 2016).","DOI":"10.1002\/9781119085263"},{"key":"6810_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0304-4165(02)00410-5","volume":"1573","author":"J Marcus","year":"2002","unstructured":"Marcus, J. & Popko, B. Galactolipids are molecular determinants of myelin development and axo-glial organization. Biochim Biophys. Acta 1573, 406\u2013413 (2002).","journal-title":"Biochim Biophys. Acta"},{"key":"6810_CR29","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.neuron.2017.06.026","volume":"95","author":"ZA Klein","year":"2017","unstructured":"Klein, Z. A. et al. Loss of TMEM106B ameliorates lysosomal and frontotemporal dementia-related phenotypes in progranulin-deficient mice. Neuron 95, 281\u2013296.e286 (2017).","journal-title":"Neuron"},{"key":"6810_CR30","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","volume":"32","author":"AS Chen-Plotkin","year":"2012","unstructured":"Chen-Plotkin, A. S. et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways. J. Neurosci. 32, 11213\u201311227 (2012).","journal-title":"J. Neurosci."},{"key":"6810_CR31","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/brain\/awaa154","volume":"143","author":"T Feng","year":"2020","unstructured":"Feng, T. et al. A role of the frontotemporal lobar degeneration risk factor TMEM106B in myelination. Brain 143, 2255\u20132271 (2020).","journal-title":"Brain"},{"key":"6810_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.mcn.2014.07.006","volume":"61","author":"M Stagi","year":"2014","unstructured":"Stagi, M., Klein, Z. A., Gould, T. J., Bewersdorf, J. & Strittmatter, S. M. Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B. Mol. Cell Neurosci. 61, 226\u2013240 (2014).","journal-title":"Mol. Cell Neurosci."},{"key":"6810_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1373\/clinchem.2008.115873","volume":"55","author":"S Martino","year":"2009","unstructured":"Martino, S. et al. Specific determination of beta-galactocerebrosidase activity via competitive inhibition of beta-galactosidase. Clin. Chem. 55, 541\u2013548 (2009).","journal-title":"Clin. Chem."},{"key":"6810_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0009-8981(05)80003-8","volume":"205","author":"G Wiederschain","year":"1992","unstructured":"Wiederschain, G., Raghavan, S. & Kolodny, E. Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D- galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease. Clin. Chim. Acta 205, 87\u201396 (1992).","journal-title":"Clin. Chim. Acta"},{"key":"6810_CR35","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1523\/JNEUROSCI.6383-09.2010","volume":"30","author":"WC Lee","year":"2010","unstructured":"Lee, W. C. et al. Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones. J. Neurosci. 30, 5489\u20135497 (2010).","journal-title":"J. Neurosci."},{"key":"6810_CR36","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2006.03.005","volume":"23","author":"WC Lee","year":"2006","unstructured":"Lee, W. C. et al. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD). Neurobiol. Dis. 23, 273\u2013280 (2006).","journal-title":"Neurobiol. Dis."},{"key":"6810_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.410190306","volume":"19","author":"A Brun","year":"1986","unstructured":"Brun, A. & Englund, E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19, 253\u2013262 (1986).","journal-title":"Ann. Neurol."},{"key":"6810_CR38","doi-asserted-by":"publisher","unstructured":"Migliaccio, R. et al. White matter atrophy in Alzheimer\u2019s disease variants. Alzheimers Dement. https:\/\/doi.org\/10.1016\/j.jalz.2012.04.010 (2012).","DOI":"10.1016\/j.jalz.2012.04.010"},{"key":"6810_CR39","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1001\/archneur.60.3.393","volume":"60","author":"G Bartzokis","year":"2003","unstructured":"Bartzokis, G. et al. White matter structural integrity in healthy aging adults and patients with Alzheimer disease: a magnetic resonance imaging study. Arch. Neurol. 60, 393\u2013398, (2003).","journal-title":"Arch. Neurol."},{"key":"6810_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000051183","volume":"9","author":"E Englund","year":"1998","unstructured":"Englund, E. Neuropathology of white matter changes in Alzheimer\u2019s disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 9, 6\u201312 (1998).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"6810_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1001\/archneur.1996.00550080056013","volume":"53","author":"JC Stout","year":"1996","unstructured":"Stout, J. C., Jernigan, T. L., Archibald, S. L. & Salmon, D. P. Association of dementia severity with cortical gray matter and abnormal white matter volumes in dementia of the Alzheimer type. Arch. Neurol. 53, 742\u2013749 (1996).","journal-title":"Arch. Neurol."},{"key":"6810_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady, S. E., Rizvi, B., Goldman, J. E. & Brickman, A. M. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 6, 22 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"6810_CR43","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han, X., D, M. H., McKeel, D. W. Jr., Kelley, J. & Morris, J. C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J. Neurochem. 82, 809\u2013818 (2002).","journal-title":"J. Neurochem."},{"key":"6810_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jnc.12368","volume":"127","author":"H Cheng","year":"2013","unstructured":"Cheng, H., Wang, M., Li, J. L., Cairns, N. J. & Han, X. Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer\u2019s disease: an early event in disease pathogenesis. J. Neurochem. 127, 733\u2013738 (2013).","journal-title":"J. Neurochem."},{"key":"6810_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1600-0404.1989.tb03886.x","volume":"80","author":"A Wallin","year":"1989","unstructured":"Wallin, A., Gottfries, C. G., Karlsson, I. & Svennerholm, L. Decreased myelin lipids in Alzheimer\u2019s disease and vascular dementia. Acta Neurol. Scand. 80, 319\u2013323 (1989).","journal-title":"Acta Neurol. Scand."},{"key":"6810_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ana.10618","volume":"54","author":"X Han","year":"2003","unstructured":"Han, X. et al. Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia. Ann. Neurol. 54, 115\u2013119 (2003).","journal-title":"Ann. Neurol."},{"key":"6810_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-021-00488-7","volume":"16","author":"S Qiu","year":"2021","unstructured":"Qiu, S. et al. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment. Mol. Neurodegener. 16, 64 (2021).","journal-title":"Mol. Neurodegener."},{"key":"6810_CR48","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell 160, 1061\u20131071 (2015).","journal-title":"Cell"},{"key":"6810_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45692-3","volume":"15","author":"H Takahashi","year":"2024","unstructured":"Takahashi, H. et al. Reduced progranulin increases tau and alpha-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase. Nat. Commun. 15, 1434 (2024).","journal-title":"Nat. Commun."},{"key":"6810_CR50","doi-asserted-by":"publisher","first-page":"103670","DOI":"10.1016\/j.mcn.2021.103670","volume":"116","author":"M Blomqvist","year":"2021","unstructured":"Blomqvist, M., Zetterberg, H., Blennow, K. & Mansson, J. E. Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration. Mol. Cell Neurosci. 116, 103670 (2021).","journal-title":"Mol. Cell Neurosci."},{"key":"6810_CR51","doi-asserted-by":"publisher","first-page":"e50197","DOI":"10.15252\/embr.202050197","volume":"21","author":"X Zhou","year":"2020","unstructured":"Zhou, X. et al. Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin-deficient mice. EMBO Rep. 21, e50197 (2020).","journal-title":"EMBO Rep."},{"key":"6810_CR52","doi-asserted-by":"publisher","first-page":"fcaa200","DOI":"10.1093\/braincomms\/fcaa200","volume":"3","author":"A Perez-Canamas","year":"2021","unstructured":"Perez-Canamas, A., Takahashi, H., Lindborg, J. A. & Strittmatter, S. M. Fronto-temporal dementia risk gene TMEM106B has opposing effects in different lysosomal storage disorders. Brain Commun. 3, fcaa200 (2021).","journal-title":"Brain Commun."},{"key":"6810_CR53","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-4939-1258-2_13","volume":"1198","author":"M Wang","year":"2014","unstructured":"Wang, M. & Han, X. Multidimensional mass spectrometry-based shotgun lipidomics. Methods Mol. Biol. 1198, 203\u2013220 (2014).","journal-title":"Methods Mol. Biol."},{"key":"6810_CR54","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1194\/jlr.D500007-JLR200","volume":"46","author":"X Han","year":"2005","unstructured":"Han, X., Yang, K., Cheng, H., Fikes, K. N. & Gross, R. W. Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatization. J. Lipid Res. 46, 1548\u20131560 (2005).","journal-title":"J. Lipid Res."},{"key":"6810_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1471-4159.2006.04342.x","volume":"101","author":"H Cheng","year":"2007","unstructured":"Cheng, H., Jiang, X. & Han, X. Alterations in lipid homeostasis of mouse dorsal root ganglia induced by apolipoprotein E deficiency: a shotgun lipidomics study. J. Neurochem. 101, 57\u201376 (2007).","journal-title":"J. Neurochem."},{"key":"6810_CR56","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1021\/acs.analchem.7b02058","volume":"89","author":"M Wang","year":"2017","unstructured":"Wang, M., Palavicini, J. P., Cseresznye, A. & Han, X. Strategy for quantitative analysis of isomeric bis(monoacylglycero)phosphate and phosphatidylglycerol species by shotgun lipidomics after one-step methylation. Anal. Chem. 89, 8490\u20138495 (2017).","journal-title":"Anal. Chem."},{"key":"6810_CR57","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/rcm.3595","volume":"22","author":"X Han","year":"2008","unstructured":"Han, X., Yang, K. & Gross, R. W. Microfluidics-based electrospray ionization enhances the intrasource separation of lipid classes and extends identification of individual molecular species through multi-dimensional mass spectrometry: development of an automated high-throughput platform for shotgun lipidomics. Rapid Commun. Mass Spectrom. 22, 2115\u20132124 (2008).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"6810_CR58","doi-asserted-by":"crossref","unstructured":"Wang, M., Wang, C., Han, R. H. & Han, X. Novel advances in shotgun lipidomics for biology and medicine. Prog. Lipid Res. 61, 83\u2013108 (2016).","DOI":"10.1016\/j.plipres.2015.12.002"},{"key":"6810_CR59","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1021\/ac900241u","volume":"81","author":"K Yang","year":"2009","unstructured":"Yang, K., Cheng, H., Gross, R. W. & Han, X. Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. Anal. Chem. 81, 4356\u20134368 (2009).","journal-title":"Anal. Chem."},{"key":"6810_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ymeth.2006.05.004","volume":"39","author":"J Bielawski","year":"2006","unstructured":"Bielawski, J., Szulc, Z. M., Hannun, Y. A. & Bielawska, A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39, 82\u201391 (2006).","journal-title":"Methods"},{"key":"6810_CR61","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/978-1-60761-322-0_22","volume":"579","author":"J Bielawski","year":"2009","unstructured":"Bielawski, J. et al. Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol. Biol. 579, 443\u2013467 (2009).","journal-title":"Methods Mol. Biol."},{"key":"6810_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/978-1-4419-6741-1_3","volume":"688","author":"J Bielawski","year":"2010","unstructured":"Bielawski, J. et al. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS). Adv. Exp. Med Biol. 688, 46\u201359 (2010).","journal-title":"Adv. Exp. Med Biol."},{"key":"6810_CR63","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00401-017-1668-z","volume":"133","author":"H Takahashi","year":"2017","unstructured":"Takahashi, H. et al. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Acta Neuropathol. 133, 785\u2013807 (2017).","journal-title":"Acta Neuropathol."},{"key":"6810_CR64","doi-asserted-by":"publisher","first-page":"105862","DOI":"10.1016\/j.nbd.2022.105862","volume":"174","author":"D Iacono","year":"2022","unstructured":"Iacono, D. et al. Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease. Neurobiol. Dis. 174, 105862 (2022).","journal-title":"Neurobiol. Dis."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06810-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:17:15Z","timestamp":1725524235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06810-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6810"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06810-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.14.557804","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1088"}}